0.28
-0.0273(-8.76%)
Currency In USD
| Previous Close | 0.31 |
| Open | 0.31 |
| Day High | 0.3 |
| Day Low | 0.28 |
| 52-Week High | 2.3 |
| 52-Week Low | 0.21 |
| Volume | 560,373 |
| Average Volume | 1.45M |
| Market Cap | 69.22M |
| PE | -0.35 |
| EPS | -0.81 |
| Moving Average 50 Days | 0.38 |
| Moving Average 200 Days | 0.94 |
| Change | -0.03 |
If you invested $1000 in Scilex Holding Company (SCLX) since IPO date, it would be worth $28.88 as of March 13, 2025 at a share price of $0.285. Whereas If you bought $1000 worth of Scilex Holding Company (SCLX) shares 3 years ago, it would be worth $28.03 as of March 13, 2025 at a share price of $0.285.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025
GlobeNewswire Inc.
Mar 10, 2025 1:00 PM GMT
PALO ALTO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products fo
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025
GlobeNewswire Inc.
Jan 31, 2025 2:00 PM GMT
US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any shares of the Dividend Stock (including any such
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication
GlobeNewswire Inc.
Jan 22, 2025 1:00 PM GMT
PALO ALTO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for